A risk score model to predict in-hospital mortality of patients with end-stage renal disease and acute myocardial infarction

被引:0
作者
Yuan Fu
Hao Sun
Zongsheng Guo
Li Xu
Xinchun Yang
Lefeng Wang
Kuibao Li
Mulei Chen
Yuanfeng Gao
机构
[1] Chaoyang Hospital,Department of Cardiology
[2] Capital Medical University,undefined
来源
Internal and Emergency Medicine | 2021年 / 16卷
关键词
Risk score model; Acute myocardial infarction; Chronic kidney disease; End-stage renal disease; Continuous renal replacement therapy; The GRACE risk score;
D O I
暂无
中图分类号
学科分类号
摘要
Chronic kidney disease (CKD) significantly increases the rate of adverse cardiovascular events in patients with coronary artery disease. In this study, we aimed to establish a risk score (RS) model to predict in-hospital mortality risk in patients with end-stage renal disease (ESRD) and acute myocardial infarction (AMI). A total of 113 consecutive patients with ESRD and AMI were retrospectively enrolled between January 1, 2015 and December 31, 2019. All patients received regular hemodialysis and were divided into two groups according to the prognosis during hospitalization. Univariable and multivariable logistic regression analyses were used to identify the risk factors of in-hospital mortality. A RS model was developed based on multiple regression analysis and was internally validated using 1000 bootstrap analysis. The receiver operating characteristic (ROC) curve was performed, and the area under curve (AUC) was analyzed to evaluate the performance of the RS model. AUCs were compared using the Z test. Thirty-three patients died during hospitalization, resulting in in-hospital mortality rate of 29.2%. After multivariate logistic regression, an RS model (0–8) was established based on five independent factors that were assigned with different points according to relative coefficients (coefficient of the index risk factor divided by the lowest coefficient among these five risk factors; rounded to closest integer): 1 for C-reactive protein (CRP) ≥ 14.2 mg/L and left ventricular ejection fraction (LVEF) ≤ V3%; 2 for age ≥ 65 years old, heart rate (HR) at admission ≥ 86 beats per minute (bpm) and d-dimer ≥ 2.4 mg/L FEU. The present RS model had a sensitivity of 85.7%, the specificity of 84%, and an accuracy of 78.1%. In ROC curve analysis, the model demonstrated a good discriminate power in predicting in-hospital mortality (AUC = 0.895, 95% CI 0.814–0.96; P < 0.001), which was significantly better than the predictive power of the Global Registry of Acute Coronary Events risk score (GRACE RS) (AUC = 0.754, 95% CI 0.641–0.868; P < 0.001 after Z test). A novel RS model, which was established to help predict in-hospital mortality of patients with ESRD and AMI, was easy to use and had higher accuracy than the GRACE RS.
引用
收藏
页码:905 / 912
页数:7
相关论文
共 299 条
[1]  
Alan S(2004)Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296-1305
[2]  
Go GMC(2020)Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial Nephrol Dial Transplant 35 1369-1376
[3]  
Fan D(2017)Management and outcomes of acute myocardial infarction in patients with chronic kidney disease Int J Cardiol 227 1-7
[4]  
McCulloch CE(2019)Efficacy and safety of ticagrelor compared with clopidogrel in patients with end-stage renal disease with acute myocardial infarction Am J Cardiovasc Drugs 19 325-334
[5]  
Hsu C-Y(2015)Treatment of symptomatic coronary artery disease in patients with end-stage renal disease on hemodialysis with paclitaxel-eluting TAXUS stent Hemodial Int 19 402-411
[6]  
Lima EG(2017)Cardiovascular outcome trials in patients with advanced kidney disease: time for action Circulation 135 1769-1771
[7]  
Charytan DM(2020)Management of coronary disease in patients with advanced kidney disease N Engl J Med 382 1608-1618
[8]  
Hueb W(2014)2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary J Am Coll Cardiol 64 2645-2687
[9]  
de Azevedo DFC(2020)Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction Eur Heart J 24 1655-1661
[10]  
Garzillo CL(2006)Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings J Hypertens 71 251-258